
Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV administration of the medication, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
When patients with a suspected or diagnosed delayed-type hypersensitivity (DTH) to heparin are having an emergency, open heart surgery or hemodialysis, they can take the drug via IV, Axel Trautmann, MD, of the department of dermatology and allergy at the University Hospital Würzburg in Germany, and colleagues wrote in the study. DTH responses typically include